In the US, Ocufen (flurbiprofen ophthalmic) is a member of the drug class ophthalmic anti-inflammatory agents and is used to treat Inhibition of Intraoperative Miosis and Postoperative Ocular Inflammation.
- OCUFEN OPHTHALMIC SOLUTION 0.03% W/V (Leaflet)
Ingredient matches for Ocufen
Bromfenac sodium (a derivative of Bromfenac) is reported as an ingredient of Ocufen in the following countries:
Flurbiprofen is reported as an ingredient of Ocufen in the following countries:
Flurbiprofen sodium (a derivative of Flurbiprofen) is reported as an ingredient of Ocufen in the following countries:
- New Zealand
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.